Cargando…
The ‘Ins and Outs’ of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong?
In this perspective, we congratulate the international efforts to highlight critical challenges in brain tumor research through a recent Consensus Statement. We also illustrate the importance of developing more accurate and clinically relevant early translational in vitro brain tumor models—a perspe...
Autores principales: | Rominiyi, Ola, Al-Tamimi, Yahia, Collis, Spencer J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468723/ https://www.ncbi.nlm.nih.gov/pubmed/30934632 http://dx.doi.org/10.3390/cancers11030426 |
Ejemplares similares
-
COVID-19 and antimalarials. Have we been doing it wrong all along?
por: Cismaru, Cosmin Andrei, et al.
Publicado: (2021) -
Have we been qualifying measurable residual disease correctly?
por: Feng, Yahui, et al.
Publicado: (2023) -
Tumour treating fields therapy for glioblastoma: current advances and future directions
por: Rominiyi, Ola, et al.
Publicado: (2020) -
Correction: Tumour treating fields therapy for glioblastoma: current advances and future directions
por: Rominiyi, Ola, et al.
Publicado: (2021) -
50 Years of Women in Cell Biology: Where have we been? Where are we going?
por: Masur, Sandra K., et al.
Publicado: (2021)